Innovative gene transfer strategies for tumour treatment
Genenta Science has raised €9.3M across 2 funding rounds, most recently a Series A round in Mar 2015. Based in Milan, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2015-03-01 | Series A | €3.4M | — | View deal → |
| 2015-01-01 | Series A | €5.9M | — | View deal → |
